ESC 365 - Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

ESC Premium Access

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

Session: Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

Topic: Surgery

Speaker: Associate Professor M. Banovic (Belgrade, RS)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Associate Professor Marko Banovic

University Clinical Center of Serbia, Belgrade (Serbia)

1 presentation

0 follower

7 more presentations in this session

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Speaker: Doctor A. Masri (Portland, US)

Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Speaker: Doctor J. Spertus (Kansas City, US)

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Speaker: Doctor S. Hegde (Boston, US)

Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

Speaker: Doctor A. Masri (Portland, US)

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial

Speaker: Professor S. Bleiziffer (Bad Oeynhausen, DE)

Access the full session

Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

Speakers: Associate Professor M. Banovic, Doctor A. Masri, Doctor J. Spertus, Doctor S. Hegde, Doctor A. Masri...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources